Erectile Dysfunction Etiological Factors by Rafaela Rosalba de Mendonça et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
2 
Erectile Dysfunction  
Etiological Factors 
Rafaela Rosalba de Mendonça1, Fernando Korkes1  
and João Paulo Zambon2,3  
1ABC School of Medicine /  
2Albert Einstein Hospital /  
3Federal University of São Paulo, 
Brazil 
 
1. Introduction 
The prevalence of ED in men between 40 and 70 years old is approximately 50%. 
(Massachusetts Male Aging Study). There are many ED etiological factors, such as 
psychological, vascular, neurological and hormonal disorders. (Tomada, 2010; Kavoussi, 
2007; Glina 2002). 
In accordance with the International Society of Impotence Research, ED may be classified 
into three subtypes: organic (that includes iatrogenic, neurogenic, vasculogenic and 
hormonal), psychogenic and mixed erectile dysfunction. A thorough investigation ought to 
be performed by a multidisciplinary team in order to avoiding misdiagnosis. (Kavoussi, 
2007) 
The basic assessment is suggested by ED guidelines: detailed anamnesis and physical 
examination, fast serum glucose, total cholesterol and fractions, triglycerides and 
testosterone level. Long history of diabetes, alcohol abuse and spinal cord injuries suggest 
neurological ethiology. (Kavoussi; Tanagho & McAninch, 2007). 
Patients without contra-indications must be recommended to use 5 phosphodiesterase 
(PDE5) inhibitors after first visit. Vascular integrity may be tested by PDE5  inhibitors 
response and good drug response usually mean vascular integrity. (Tanagho & McAninch, 
2007; Glina, 2002) 
Recent studies have demonstrated the association between ED and cardiovascular diseases 
Zambon, 2010; Bal, 2007. Ultrasensible C Reactive Protein (CRP) is an early marker of 
cardiovascular risk, and patients with ED have higher levels of CRP. Risk factors such as 
hypertension, smoking, obesity, diabetes mellitus, metabolic syndrome and sedentary 
lifestyle are pretty common in patients with coronary disease and ED (Zambon, 2010; Bal, 
2007).   
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Fig. 1. Initial ED evaluation 
Medical history 
Physical examination 
Psychological assessment 
Laboratorial tests 
Serum glycose 
Cholesterol
Triglycerides 
Testosterone 
Prolactin when testosterone 
level is low 
Drug-induced erection test. 
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2. Etiological factors 
ORGANIC
  Vasculogenic
  Arteriogenic
  Smoking
  Trauma
  Dislipidemia
  Hypertension
  Diabetes Mellitus
  Pelvic irradiation
  Pelvic surgery
  Cavernosal
  Neurogenic
  Central 
  Parkinson disease
  Encephalitis
  Vascular Stroke
  Brain Tumor
  Multiple Sclerosis 
  Alzheimer 
  Spinal cord injury
  Disc herniation
  Peripheral
  Pelvic surgery
  Retroperitoneal surgery
  Diabetes Mellitus
  Alcohol
  Polineuropathic
  Endocrinologic
  Hypogonadism
  Hyperprolactinemia
  Diabetes Mellitus
  Dyslipidemia
  Thyroid hormones
  Adrenal hormones
  Estradiol changes
  Anatomic
  Peyronie disease
  Penile fracture
Table 1. ED organic causes 
2.1 Anatomic factors 
The most frequent physiopathology of these dysfunctions is low abnormal drainage, or 
severe alterations of penile geometry. Peyronie's disease, priapism and penile trauma are 
some examples of anatomic etiological factors. Physical examination can confirm penile 
shaft fibrosis, and Doppler ultrasound can identify the fibrosis with good sensitivity and 
specificity (Navarro, 2010; Persu, 2009).  
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2.2 Endocrinological factors 
The endocrine disorders are directly or indirectly related with erection mechanism. 
Endocrine disorders can be associated or worsen the pre-existing ED. Among the etiological 
factors we can point out diabetes mellitus, obesity, hypogonadism, adrenals and thyroid 
dysfunction and Hyperprolactinemia. (Tanagho & McAninch, 2007; Kavoussi; Jabaloyas, 
2010; Persu, 2009) 
2.2.1 Diabetes mellitus 
Diabetes Mellitus (DM) is one of the most frequent etiologies of ED. Patients with higher 
levels of glucose and glycated hemoglobin has higher risk of ED. The prevalence of ED in 
men with DM ranges from 10 to 90%. Risk factors for the emergence of ED in diabetic 
patients are: disease time, age, sedentary lifestyle and glycemic control. (Jabolayas, 2010) 
Regarding PDE 5 inhibitors response, diabetic patients have lower response than normal 
patients. Furthermore, it is directly related to disease severity. Vascular and autonomic 
neuropathies are the main etiological alterations observed in diabetic patients. The main 
pathophysiological mechanisms proposed for ED in diabetic patients include the release of 
free radicals, increased endothelin receptor B, impaired nitric oxide synthesis and up-
regulated RhoA/Rho-kinase pathway. (Jabolayas, 2010; Thorve, 2011; Moore, 2006) 
2.2.2 Hypogonadism 
Low testosterone level can decrease the libido, the morning erections and penile tumescence. It 
can also increase the risk of depression and psychiatric disorders. Furthermore, hypogonadic 
patients with ED have higher risk of early osteoporosis. (Tanagho & McAninch, 2007) 
Studies have shown that hypogonadic men present high risk of metabolic syndrome and 
DM. The symptoms which are related to hypogonadism are common to many others 
diseases. It is advisable at least 2 consecutive dosages of total testosterone in the period 
between 7 and 11 a.m. The institution of compulsory treatment should be based on clinical 
and total dosage of testosterone. Moreover, hypogonadic patients may clinically present 
primary or secondary infertility. Thyroid, pituitary and adrenal disorders are less common 
etiologies, and in specific situations, alterations must be taken into account. (Traish, 2009) 
2.2.3 Hyperprolactinemia 
Hyperprolactinemia may be associated with reduced libido. The prevalence of 
hyperprolactinemia in men with ED varies between 2 and 13%. Prolactin above 35 ng/mL 
are associated with ED and decreased libido. (Jabolayas, 2010) 
The mechanism by which elevated prolactin leads to ED, is not fully understood. This 
change is attributed to the reduction of testosterone and alterations in the pulsatile release of 
LH. There are several causes for elevated prolactin, for instance pituitary adenoma (most 
common cause), drugs (especially antipsychotics), chronic renal failure and herpes zoster. 
(Jabaloyas, 2010) 
Guidelines recommended prolactin dosage when testosterone levels are low. The gold 
standard exam to evaluate pituitary adenoma is the magnetic ressonance imaging. (Tanagho 
& McAninch, 2007) 
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2.2.4 Changes in thyroid hormones 
Changes in thyroid hormones are also associated with changes in libido, erectile function 
and ejaculation. The prevalence of thyroid diseases is variable and normalization of 
hormone levels can restore an adequate erection when the ethiology is the thyroid 
dysfunction .The hypothyroidism can decrease levels of free testosterone and SHBG, and 
hyperthyroidism appears to be strictly related to changes in libido. (Jabolayas, 2010; Cauni, 
2009). 
2.2.5 Dyslipidemia 
Dyslipidemia is a risk factor for ED, and some patients are diagnosed during the ED 
investigation. The change in lipid metabolism is associated with endothelial dysfunction 
and abnormal relaxation of smooth muscle. (Vrentzos, 2007; Jabaloyas, 2010) 
Hypercholesterolemia, high level of LDL and low HDL increase the risk of atherosclerosis, 
which may change the penile blood flow. Besides, hypercholesterolemia increases the pro-
inflammatory markers and endothelial dysfunction. (Vrentzos, 2007; Bal, 2007) 
Studies demonstrated a positive correlation between cardiovascular risks, 
hypercholesterolemia and erectile dysfunction (Zambon, 2010; Koenig, 2004) have 
demonstrated that men with ED had higher levels of C-reactive protein, which is an early 
marker of endothelial dysfunction and cardiovascular diseases. (Zambon, 2010; Koenig, 2004) 
2.2.6 Changes of adrenal hormones 
The role of adrenal hormones and their changes are not well established in the etiology of 
ED. Studies have correlated the low levels of dehydroepiandrosterone with ED. 
Androstenedione can be converted into testosterone and supplementation of this hormone 
may improve erectile function. Nevertheless, there is no justification dosage of adrenal 
hormones in the initial investigation of ED. In specific cases, the dosage of hormones 
produced in the adrenal, for example, cortisol, aldosterone, androstenedione, 
dehydroepiandrosterone, among others, is recommended. (Jabolayas 2010) 
2.2.7 Changes in estradiol 
The increased production of estradiol in men can be associated with ED. Elevated estrogen 
levels decrease the production of testosterone by inhibiting the LH production. The chronic 
liver disease may be related with the hyperestrogenism. Another uncommon etiology of 
hyperestrogenism is the endocrinologic neoplasms. (Jabolayas, 2010) 
2.3 Vascular factors 
The vascular dysfunctions are common in men with ED. Commonly, the vasoreactivity is 
reduced, and consequently low penile blood flow, hypoxia and fibrosis are the final results. 
These changes decrease the penile shaft stiffness over the time. (Tomada, 2010; Cauni, 2009; 
Odriozola, 2010) 
ED seems to be an early marker of endothelial dysfunction, which can changes the 
vasoreactive substances production, such as nitric oxide and endothelin (Odriozola, 2010; 
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Hannan, 2010). Local growth factors seem also to be involved in the pathophysiology. 
Therefore, there is a reduced response to vasodilating substances and an increased 
sensitivity to vasoconstrictor agents. (Odriozola, 2010; Hannan, 2010) 
Penile vascular abnormalities are strictly linked to cardiovascular risk factors such as 
hypertension, smoking, dyslipidemia, and DM among others. Diffuse and bilateral lesions 
in internal pudendal arteries, penile and cavernous as well are common in patients with 
atherosclerosis. (Odriozola, 2010, Hannan, 2010) 
The evaluation of penile vascular function can be performed using Doppler ultrasound, 
magnetic resonance image or angiography, however, the real significance of these tests 
remains unclear.  
2.4 Neurologic factors  
The prevalence of ED as a consequence of neurological diseases ranges from 10 to 19%. In 
these cases, ED is moderate or severe, with poor response to oral therapy. (Cauni, 2009; 
Antuna, 2008) 
The neurogenic etiology can be central or peripheral. Central disorders can be exemplified 
by Parkinson's disease, brain tumor, encephalitis, cerebral strokes, cranial trauma, epilepsy 
and multiple sclerosis. In the other hand, DM, spinal cord injury, and surgical trauma of the 
erector nerves during radical prostatectomy, polyneuropathy metabolic, toxic or congenital 
conditions among others, can be cited as peripheral neurogenic disorders. (Cauni, 2009; 
Antuna, 2008) 
The basic neurological assessment  must be performed in all patients with ED. Guidelines 
recommended the spinal cord reflexes evaluation, for example bulbocavernosum reflex, and 
sensitivity level. (Kavoussi, 2007) 
2.4.1 Dysfunctional system 
Multiple sclerosis is characterized by multiple areas of demyelization of the central nervous 
system. The prevalence of ED in men with multiple sclerosis is approximately 60%. 
Generally, multiple sclerosis is a progressive disease, with periods of acute crisis and 
remission. In the initial profiles, ED is mild; however, with the evolution of the disease, it 
becomes severe and unresponsive to conservative therapy. (Antuna, 2008) 
Parkinson's disease is a neurodegenerative disease characterized by progressive decrease of 
gray matter's dopaminergic neurons. This process can achieve the mesolimbic and 
mesocortical regions and areas of the autonomic nervous system. Drug therapy with PDE-5 
inhibitors can produce satisfactory results, but a careful analysis of these patients should be 
performed in order to improve the results and patient satisfaction. (Antuna, 2008) 
In patients with epilepsy, the prevalence of ED is variable and the ethiology is multifactorial. 
ED secondary to cerebral strokes depends on many factors such as age, location and extent 
of stroke. Furthermore, co-morbidities and co-related diseases can worsen the ED prognosis. 
In general, traumas also can be associated with ED. Many patients develop psychogenic 
disorders, which may raise the ED incidence. (Antuna, 2008) 
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2.4.2 Spinal cord injuries 
The spinal cord trauma is usually associated with automobilistic crashes. Generally, this 
kind of trauma affects the younger population who are economically active and the initial 
care of these patients should be performed by a multidisciplinary team, to avoid late sequel. 
(Kavoussi, 2007) 
After the trauma, there is a phase of spinal shock, which has a variable duration, what 
occurs is a reflex abolition below the affected area. Over the time with spinal shock recovery, 
patients may have reflex erections. (Kavoussi, 2007) 
The post spinal cord trauma depends on the level, extent and severity of trauma. In general, 
ED tends to be moderate to severe, and semen quality in these patients most frequently is 
poor. The use of medications can provide satisfactory results in some patients. A second 
option is the intracavernosal injections and penile prosthesis, which can be performed when 
other options did not have a good result. (Antuna, 2008) 
In conclusion, the treatment of patients with spinal cord trauma should be individualized 
and carried out by a multidisciplinary team. (Antuna, 2008) 
2.4.3 Peripheral dysfunction 
The peripheral neuropathy may be related with many differents etiologies. The clinical 
manifestation is quite variable and the correct diagnosis must be made as always as possible 
to avoid unsuccessful treatment. ED is a symptom of this syndrome. In Brazil, in addition to 
DM, there is an increasing incidence of alcoholic polyneuropathy, due to the excessive 
consumption of alcoholic beverages. In this case, ED occurs late and is often irreversible. 
(Antuna, 2008; Abdo, 2006) 
2.5 Pelvic surgery 
Excluding skin cancer, prostate cancer is more common in men after age 60. Radical 
retropubic prostatectomy is the gold standard treatment of prostate cancer. The prostate-
specific antigen (PSA) screening programs improve the early detection of this disease. 
(Zippe, 2006) 
ED is a major surgical post-operative complication after pelvic surgery. The prevalence of 
ED after radical retropubic prostatectomy is approximately 50%, but depends on factors 
such as age, tumor stage, surgical technique, associated comorbidities, among others. The 
manipulation of the periprostatic nerve plexus can cause a transient neurological injury 
(neuropraxia) or permanent (neurovascular bundle injury). These lesions can induce 
hypoxia and collagen deposition in the corpus cavernosum. (Zippe, 2006; Gallina, 2010) 
The vessel damage during surgery such as in the accessory pudendal arteries may cause a 
vascular insufficiency, by changing the irrigation of the erectile tissue. Furthermore, ligation 
of anomalous pudendal artery branches or venous plexus can induce the formation of 
fibrosis in the corpus cavernosum. (Zippe, 2006; Gallina, 2010) 
ED can also occur after surgery to remove colon cancer, which is the most common cancers 
of the distal colon and at the junction between the rectum and sigmoid.  Thus, the ED 
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incidence in patients undergoing colorectal cancer surgery varies between 10-60%. This 
incidence increases when there is need for neoadjuvant or radiotherapy adjuvant. A 
permanent colostomy also increases the rate of dysfunction to leading to alteration in body 
image. (Zippe, 2006; Gallina, 2010) 
2.6 Cardiovascular risk factors  
ED may be related to cardiovascular risk and may precede a cardiovascular event in 3-5 
years. Studies have shown that ED is an early marker of endothelial dysfunction and 
atherosclerotic disease (Bryan, 2011; Blumentals, 2004).  
The prevalence of ED in men with cardiovascular disease varies between 44 and 75%. 
(Muller & Mulhall, 2006). There is a strong correlation between cardiovascular disease and 
ED, since the risk factors are the same, such as hypertension, dyslipidemia, obesity, 
smoking, DM and sedentary lifestyle (Kupelian, 2006; Bal, 2007; Feldman, 2000; Derby, 2000)  
The endothelium and the cavernous nerves are two sources of nitric oxide. Nitric oxide acts 
on smooth muscle relaxation during erection. The production and release of this substance 
depends on the integrity of endothelium. A nitric oxide response in men with ED is lower 
than in men with a preserved erection (Muller & Mulhall, 2006; Giugliano, 2004). 
Endothelial dysfunction is an early stage of vascular damage. Cardiovascular risk factors 
can cause endothelial damage leading to an impaired nitric oxide release, atherosclerosis 
and vascular stenosis. Endothelial dysfunction seems to play an important role in the 
development of both ED and cardiovascular diseases. Organic erectile dysfunction in a 
majority of men is due to the vascular diseases. (Muller & Mulhall, 2006).  
Obesity is a multifactorial disease with high prevalence worldwide. Genetic, environmental 
and behavioral factors were identified as etiological factors.  The incidence of obesity in men 
with ED is 30% higher than men without ED, (Muller & Mulhall, 2006). It is usually 
associated with other diseases such as, dyslipidemia, diabetes mellitus and hypertension.. In 
obese ones there is a peripheral resistance to insulin and a consequent hyperinsulinemia. 
Patients with higher body mass index are at greater risk of ED, even at the prospect of 
weight loss. Clinical factors like waist-hip ratio, body mass index and resting heart rate are 
significantly higher in patients with ED (Muller & Mulhall, 2006; Zambon, 2010). 
Regarding hypertension, it has been demonstrated that the chronic changes in blood 
pressure, altering the flow of small vessels and penile vessels, which are associated with the 
development of the atherosclerotic disease can cause severe ED. A number of anti-
hypertensive medications, such as beta-blocking drugs may have ED as a side effect (Muller 
& Mulhall, 2006).  
Smoking as above mentioned is a risk factor for ED. It changes the mechanism of penile 
erection because it affects the smooth muscle relaxation. The prevalence among men with 
ED is 27.3% vs. 12.5% among men without ED. Not only the smoker, but passive exposure 
to cigarette smoke has a higher incidence of erectile dysfunction.Therefore, smoking 
increase the ED grade. (Feldman, 2000; Zambon, 2010; Muller & Mulhall, 2006). 
Metabolic syndrome is also a significant risk factor in patients aged 40 to 49. In elderly men, 
this effect of metabolic syndrome on erectile function was not prominent, probably because 
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aging itself is a risk factor for erectile dysfunction. (Bal, 2007) ED may provide a warning 
sign and an opportunity for early intervention among men who had previously been 
considered to have lower risk of metabolic syndrome and cardiovascular disease (Kupelian, 
2006; Muller & Mulhall, 2006; Zambon, 2010). 
Preventive actions such as regular diet, physical activity, and hypertension and diabetes 
controls can decrease these risks and improve erectile function (Kratsky, 2009; Derby, 2000). 
 
Fig. 2. Metabolic syndrome 
2.7 Chronic renal failure 
ED has a high incidence in patients with chronic renal failure (20-50%) and those underwent 
to renal transplantation. There is a positive relationship between the severities of both 
diseases. The cause of ED in these patients is multifactorial, including endothelial 
dysfunction, comorbidities, chronic hyperuricemia and psychogenic factors. Kidney 
transplantation can improve erectile function, due to the improvement of uremic 
neuropathy and anemia. (Phé 2008; Cauni, 2009).  
2.8 Drug induced ED 
Drug use may be responsible for up to 25% of all cases of ED. Among the medications that 
can induce it, we can highlight the drugs which affect the cardiovascular and autonomic 
nervous systems. Cauni, 2009).  
Several studies have shown that intravitreal drugs such as bevacizumab (antivascular 
endothelial growth factor) can lead to a transient ED. The mechanism is not well established, 
but it is postulated that the systemic drug absorption may lead to an interaction with nitric 
oxide in the corpus cavernosum (Yohendran & Chauhan, 2010). . Moreover, injection trauma 
can be associated with psychological effect, leading to temporary loss of erection. 
(Yohendran & Chauhan, 2010). 
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Anthyhipertensive agents
  Diuretics Thiazide
  B adrenergic blockers
  A adrenergic blockers
Antiandrogens (mechanism)
 Estrogenes 
 
Cyproterone 
acetate
 Ketoconazole
Psycotropics
  Antipsycotics
  Antidepressants
  
Monoamine oxidade 
inhibitors
  Selective serotonin reuptake inhibitors
  Tricyclics
  Anxiolitics
Digoxin 
Opiates 
Statin 
Alcohol 
Retroviral and chemothrapeutic agents
Histamine H2 receptor antagonist
Fenitoin 
Antimuscarinic
Table 2. Drugs induced ED 
2.9 Psychogenic 
In the past, psychogenic cause was considered the most important etiologic factor of ED, 
however, currently organic factors account for 60-90% of this condition. (Cauni 2009) 
The pathogenesis of psychogenic ED is not well established. Many etiological factors have been 
studied, such as: neurotransmitters imbalance, autonomic dysfunction, etc. (Kavoussi 2007) 
 
Psycogenic
Generalized
Generalized unresponsible
Generalized inhibition
Situational
Partner related
Performance related
Adjustment related
Table 3. Psycogenic ED causes 
Performance anxiety related to several different causes ends up being the most common 
cause. Other causes are: an inappropriate sex education, traumatic childhood sexual 
experiences, a troubled marriage or relationship, stressful situations or psychiatric 
disorders. (Monseny, 2010) 
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Usually, psychogenic ED has short duration. Most commonly, patients have satisfactory 
erection in specific situations. (Abdo, 2006) Socioeconomic factors such as low income and 
poor educational background also have been associated withED. (Abdo, 2006). 
3. Conclusions 
ED has a high prevalence in men over than 50 years. The incidence increase with aging and 
its ethiology appears to be multifactorial. The anamnesis and detailed physical evaluation 
ought to be performed in order to detect the main etiological factors. The best approach to 
obtain better results is to identify the main etiology. A multidisciplinary evaluation should 
be recommended for all patients.  
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